AI
By
FDA clears Felix NeuroAI, the first AI-powered noninvasive wristband for essential tremor relief for 7 Million Patients
Key Takeaways FDA Clears First AI-Driven Wristband for Essential TremorFasikl’s Felix NeuroAI Wristband has received 510(k) clearance from…
Can Argon AI’s $5.5M Funding Transform Biopharma with an AI-Native Workspace to End Data Drudgery?
Key Takeaways Argon AI Secures Strategic Backing for AI-Native Biopharma WorkspaceArgon AI has raised $5.5 million in a…
Can Catalio Capital’s $400 Million AI-Driven Life Sciences Fund Ignite a New Era of Biomedical Innovation Despite a Slow VC Market?
Key Takeaways Resilience in a Cooling VC ClimateCatalio Capital Management has successfully closed its fourth Nexus Fund at…
Is Microsoft’s AI Diagnostic Orchestrator the Beginning of the End for Traditional Doctors — With 4X Higher Accuracy Shaking Up Global Healthcare?
Key Highlights Breakthrough in Diagnostic Accuracy with Microsoft’s AIMicrosoft announced its Diagnostic Orchestrator achieved 85.5% accuracy across 304…
Could AbbVie and IGI’s $1.9B Bet on AI-Engineered Trispecific Antibody Signal a New Era for Relapsed Myeloma Treatment?
Key Highlights: AbbVie Accelerates into AI-Powered Immuno-OncologyAbbVie has entered a global licensing agreement worth up to $1.925 billion…
Can Personalis and Tempus Leverage AI to Transform Cancer Recurrence Detection for 150,000 Colorectal Patients? Strategic Expansion Deepens MRD Leadership
Key Highlights AI at the Core of Next-Gen Recurrence MonitoringThe expansion of Personalis’ NeXT Personal® MRD test into…
